Active Ingredient(s):Riluzole FDA Approved: * December 12, 1995 Pharm Company: *SANOFI AVENTIS US Category:Neurological Disorders
Riluzole is a medication used to treat amyotrophic lateral sclerosis and other motor neurone diseases. Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months. Riluzole is available in tablet and liquid form.
1 Medical use
1.1 Amyotrophic lateral sclerosis
2 Adverse effects
4 Mechanism of action
6 Society and culture
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion